
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 3
May-June 2025
Indexing Partners



















COMPARITIVE ANALYSIS OF PRESCRIPTION PATTERN IN LEUKEMIA PATIENTS: AN OBSERVATIONAL STUDY
Author(s) | Dr. Santosh Dayashankar Yadav, Dr. Viraj Nishad, Ms. Techi Yassa, Dr. Arpan Shrivastava |
---|---|
Country | India |
Abstract | Background: Leukemia, a group of blood cancers, requires complex treatment approaches including chemotherapy, targeted therapy, and supportive care. Studying real-world prescription patterns is essential for understanding adherence to clinical guidelines, managing polypharmacy, and improving evidence-based care. Objective: This study aimed to assess and compare the types and dosages of medications prescribed to leukemia patients, examine compliance with treatment protocols, and identify trends in rational prescribing. Materials and Method: A six-month prospective observational study was conducted in the Oncology Department of Sri Aurobindo Hospital, Indore. The study included 70 adult inpatients diagnosed with leukemia and having complete prescription records. Data collection involved patient interviews, review of case files, and prescription analysis. Patients with incomplete records, pediatric or geriatric age, outpatients, or those with other malignancies were excluded. Chi-square tests were used to analyze the association between adherence to treatment guidelines and patient outcomes. Result: Among the 70 patients, Acute Lymphoblastic Leukemia (ALL) was the most common (36 cases), followed by Acute Myeloid Leukemia (AML, 22), Chronic Lymphocytic Leukemia (CLL, 7), and Chronic Myeloid Leukemia (CML, 5). Methotrexate was the most commonly used antineoplastic for ALL, with Rituximab added in AML. Acivir was widely prescribed across all leukemia types. Septran-D was the most frequent antibiotic, and Voriconazole was the leading antifungal. Dexamethasone was preferred in ALL, while Hydrocortisone was commonly used in AML. Though most treatments aligned with standard protocols, statistical analysis showed no significant correlation between guideline adherence and outcomes. Conclusion: The study emphasizes the importance of regular evaluation of prescribing trends to promote rational, patient-focused, and evidence-based leukemia care—supporting insights from literature like Kumar V et al. |
Keywords | Leukemia, Prescription pattern. |
Field | Medical / Pharmacy |
Published In | Volume 7, Issue 3, May-June 2025 |
Published On | 2025-06-04 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i03.46912 |
Short DOI | https://doi.org/g9m7jz |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
